Vnitřní lékařství, 1985 (vol. 31), issue 8

[Congenital heart defects in adulthood].

I Riecanský, L Plachá, J Zelenay, K Havlínová, V Findo, I Simkovic, V Cornák

Vnitr Lek 1985, 31(8):729-735

[Post-exertional electromapping in the diagnosis of ischemic heart disease].

M Janota, V Brodan, J Lexa, J Stupka, J Fabián

Vnitr Lek 1985, 31(8):736-743

[Platelet alpha2-adrenergic receptors in essential hypertension. Methods of determining specific binding using (3H)-dihydroergocryptine and the effect of physical exertion].

P Prikryl, K Rysánek, V Vondrácek, J Prásek

Vnitr Lek 1985, 31(8):744-748

[Platelet alpha2-adrenergic receptors in essential hypertension. Number of binding sites, cyclic adenosine monophosphate and platelet aggregation].

P Prikryl, K Rysánek, V Vondrácek, M Penka, J Prásek, V Hrcková

Vnitr Lek 1985, 31(8):749-755

[Rheumatoid arthritis with antinuclear antibodies in the blood].

Z Pelísková, K Trnavský, J Vácha

Vnitr Lek 1985, 31(8):756-761

[The composition of skeletal muscle--an important factor in the pathogenesis of obesity in men].

K Vondra, D Urbanová, A Bass

Vnitr Lek 1985, 31(8):762-768

[The relation of amylase and endogenous creatinine clearance to kidney function].

J Racek, V Petríková

Vnitr Lek 1985, 31(8):769-774

[The HLA system and changes in thyroid hormones in patients].

V Felt, A Májský, P Herzog, V Vavrejnová, J Nedvídková

Vnitr Lek 1985, 31(8):775-781

[Use of the single-dimension echocardiographic examination (a scan) in the diagnosis of thyroid gland diseases. Comparison with scintigraphic and puncture findings].

V Brozková, J Smíd, F Cech, J Hůla, V Cepelák

Vnitr Lek 1985, 31(8):782-786

[Treatment of hypertension and ischemic heart disease].

J Widimský

Vnitr Lek 1985, 31(8):787-794

[Modern methods in the immunology of blood platelets].

P Korínková, A Májský

Vnitr Lek 1985, 31(8):795-801

[The relation of HLA to disease. What is the most reliable way to determine its significance?].

A Májský

Vnitr Lek 1985, 31(8):802-805

[At the present level of anticoagulation therapy with Pelentan, is it possible to expect effective prevention of thromboembolism?].

V Krislo, M Sorf, M Krislová

Vnitr Lek 1985, 31(8):806-809

[Treatment of ulcer disease using H2 antihistaminics].

L Vladár, F Hendrich, I Katuscák, R Hyrdel

Vnitr Lek 1985, 31(8):810-812
Share...

Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

No
Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.